Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 179

1.

Sporadic nonfunctioning pancreatic neuroendocrine tumors: prognostic significance of incidental diagnosis.

Birnbaum DJ, Gaujoux S, Cherif R, Dokmak S, Fuks D, Couvelard A, Vullierme MP, Ronot M, Ruszniewski P, Belghiti J, Sauvanet A.

Surgery. 2014 Jan;155(1):13-21. doi: 10.1016/j.surg.2013.08.007. Epub 2013 Nov 12.

PMID:
24238123
2.

Incidental diagnosis as prognostic factor in different tumor stages of nonfunctioning pancreatic endocrine tumors.

Crippa S, Partelli S, Zamboni G, Scarpa A, Tamburrino D, Bassi C, Pederzoli P, Falconi M.

Surgery. 2014 Jan;155(1):145-53. doi: 10.1016/j.surg.2013.08.002.

PMID:
24646958
3.

Implications of incidentally discovered, nonfunctioning pancreatic endocrine tumors: short-term and long-term patient outcomes.

Haynes AB, Deshpande V, Ingkakul T, Vagefi PA, Szymonifka J, Thayer SP, Ferrone CR, Wargo JA, Warshaw AL, Fernández-del Castillo C.

Arch Surg. 2011 May;146(5):534-8. doi: 10.1001/archsurg.2011.102.

4.

Predicting aggressive behavior in nonfunctioning pancreatic neuroendocrine tumors.

Cherenfant J, Stocker SJ, Gage MK, Du H, Thurow TA, Odeleye M, Schimpke SW, Kaul KL, Hall CR, Lamzabi I, Gattuso P, Winchester DJ, Marsh RW, Roggin KK, Bentrem DJ, Baker MS, Prinz RA, Talamonti MS.

Surgery. 2013 Oct;154(4):785-91; discussion 791-3. doi: 10.1016/j.surg.2013.07.004.

PMID:
24074416
5.

Long-term Prognosis of Resected Pancreatic Neuroendocrine Tumors in von Hippel-Lindau Disease Is Favorable and Not Influenced by Small Tumors Left in Place.

de Mestier L, Gaujoux S, Cros J, Hentic O, Vullierme MP, Couvelard A, Cadiot G, Sauvanet A, Ruszniewski P, Richard S, Hammel P.

Ann Surg. 2015 Aug;262(2):384-8. doi: 10.1097/SLA.0000000000000856.

PMID:
25185468
6.

A comprehensive comparison of clinicopathologic and imaging features of incidental/symptomatic non-functioning pancreatic neuroendocrine tumors: A retrospective study of a single center.

Luo G, Liu Z, Guo M, Jin K, Xiao Z, Liu L, Liu C, Xu J, Ni Q, Long J, Yu X.

Pancreatology. 2015 Sep-Oct;15(5):519-24. doi: 10.1016/j.pan.2015.08.009. Epub 2015 Sep 3.

PMID:
26365059
7.

Resection versus expectant management of small incidentally discovered nonfunctional pancreatic neuroendocrine tumors.

Rosenberg AM, Friedmann P, Del Rivero J, Libutti SK, Laird AM.

Surgery. 2016 Jan;159(1):302-9. doi: 10.1016/j.surg.2015.10.013. Epub 2015 Nov 4.

PMID:
26547726
8.

Surgical experience with nonfunctioning neuroendocrine tumors of the pancreas.

Matthews BD, Heniford BT, Reardon PR, Brunicardi FC, Greene FL.

Am Surg. 2000 Dec;66(12):1116-22; discussion 1122-3.

PMID:
11149582
9.

Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.

Norton JA, Kivlen M, Li M, Schneider D, Chuter T, Jensen RT.

Arch Surg. 2003 Aug;138(8):859-66.

PMID:
12912744
10.

Prognostic factors in 151 patients with surgically resected non-functioning pancreatic neuroendocrine tumours.

Song KB, Kim SC, Kim JH, Hong SM, Park KM, Hwang DW, Lee JH, Lee YJ.

ANZ J Surg. 2016 Jul;86(7-8):563-7. doi: 10.1111/ans.12738. Epub 2014 Jul 9.

PMID:
25040037
11.

Is laparoscopic resection adequate in patients with neuroendocrine pancreatic tumors?

Fernández-Cruz L, Blanco L, Cosa R, Rendón H.

World J Surg. 2008 May;32(5):904-17. doi: 10.1007/s00268-008-9467-2.

PMID:
18264824
12.

Resection of pancreatic neuroendocrine tumors: results of 70 cases.

Kazanjian KK, Reber HA, Hines OJ.

Arch Surg. 2006 Aug;141(8):765-9; discussion 769-70.

PMID:
16924083
13.

Aggressive pancreatic resection for primary pancreatic neuroendocrine tumor: is it justifiable?

Teh SH, Deveney C, Sheppard BC.

Am J Surg. 2007 May;193(5):610-3; discussion 613.

PMID:
17434366
14.

Outcomes of resected nonfunctional pancreatic neuroendocrine tumors: Do size and symptoms matter?

Sallinen V, Haglund C, Seppänen H.

Surgery. 2015 Dec;158(6):1556-63. doi: 10.1016/j.surg.2015.04.035. Epub 2015 Jun 10.

PMID:
26070847
15.

Parenchyma-sparing resections for pancreatic neuroendocrine tumors.

Cherif R, Gaujoux S, Couvelard A, Dokmak S, Vuillerme MP, Ruszniewski P, Belghiti J, Sauvanet A.

J Gastrointest Surg. 2012 Nov;16(11):2045-55. doi: 10.1007/s11605-012-2002-7. Epub 2012 Aug 22.

PMID:
22911124
16.

Nonfunctioning neuroendocrine tumors of the pancreas: clinical presentation of 7 patients.

Closset J, Delhaye M, Sperduto N, Rickaert F, Gelin M.

Hepatogastroenterology. 1996 Nov-Dec;43(12):1640-4.

PMID:
8975980
17.

Incidentally, it's still cancer.

Vollmer CM Jr.

Arch Surg. 2011 May;146(5):539. No abstract available.

PMID:
21739652
18.

Surgical treatment of incidentally identified pancreatic masses.

Fitzgerald TL, Smith AJ, Ryan M, Atri M, Wright FC, Law CH, Hanna SS.

Can J Surg. 2003 Dec;46(6):413-8.

19.

Surveillance and comparison of surgical prognosis for asymptomatic and symptomatic non-functioning pancreatic neuroendocrine tumors.

Ge W, Zhou D, Xu S, Wang W, Zheng S.

Int J Surg. 2017 Mar;39:127-134. doi: 10.1016/j.ijsu.2017.01.088. Epub 2017 Jan 27.

PMID:
28137555
20.

Parenchyma-preserving resections for small nonfunctioning pancreatic endocrine tumors.

Falconi M, Zerbi A, Crippa S, Balzano G, Boninsegna L, Capitanio V, Bassi C, Di Carlo V, Pederzoli P.

Ann Surg Oncol. 2010 Jun;17(6):1621-7. doi: 10.1245/s10434-010-0949-8. Epub 2010 Feb 17.

PMID:
20162460

Supplemental Content

Support Center